SCHEMBL873008

SCHEMBL873008

O=C(OC1CCCCCCCCC1)C(C1CCCCCCCCC1)C1CCCCCCCCC1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 4/20 0.50
CYP19A1 P11511 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.41
CYP2C19 P33261 1/20 0.39
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
CA12 O43570 2/20 0.39
CA9 Q16790 2/20 0.39
NAAA Q02083 2/20 0.38
HTT P42858 1/20 0.37
STS P08842 3/20 0.36
MMP1 P03956 1/20 0.34
MMP9 P14780 1/20 0.34
MMP12 P39900 1/20 0.34
SLC6A3 Q01959 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27569372 1.00 EPHX1 (0.50) EPHX1CYP19A1L3MBTL1CYP2C19CA1
SCHEMBL23930274 1.00 EPHX1 (0.50) EPHX1CYP19A1L3MBTL1CYP2C19CA1
SCHEMBL27528551 1.00 EPHX1 (0.50) EPHX1CYP19A1L3MBTL1CYP2C19CA1
SCHEMBL8150350 1.00 EPHX1 (0.50) EPHX1CYP19A1L3MBTL1CYP2C19CA1
SCHEMBL27437495 0.84 CYP19A1 (0.47) EPHX1CYP19A1L3MBTL1CYP2C19CA1
SCHEMBL27436950 0.81 CYP2C19 (0.44) EPHX1CYP19A1L3MBTL1CYP2C19CA1
SCHEMBL21396554 0.81 CYP19A1 (0.38) EPHX1CYP19A1L3MBTL1CYP2C19CA1
SCHEMBL14422659 0.79 EPHX1 (0.48) EPHX1CYP19A1L3MBTL1CYP2C19CA1
SCHEMBL8203394 0.79 DPP4 (0.46) EPHX1CYP19A1L3MBTL1
SCHEMBL1491556 0.79 DPP4 (0.46) EPHX1CYP19A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018145219-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING SERANI MOSTAZAL JORGE (CL) 2018-08-16 WO claimed
US-20230414474-A1 PROCESS FOR MAKING A COMPOSITION COMPRISING ALKYL POLYGLYCOSIDE AND PERFUME THE PROCTER & GAMBLE COMPANY 2023-12-28 US disclosed
CN-117090046-A Composition for reducing malodor and use thereof 阿吉莱克斯香料和香水公司 2023-11-21 CN disclosed
US-11674110-B2 Compositions containing lauryl methacrylate for malodor reduction and uses thereof AGILEX FLAVORS AND FRAGRANCES, INC (US) 2023-06-13 US disclosed
EP-3680289-B1 POLYMERIC COMPOSITION, POLYMER CAPSULE, AND FABRIC SOFTENER COMPOSITION INCLUDING SAME LG CHEMICAL LTD (KR) 2022-06-15 EP disclosed
US-11214759-B2 Polymerizable composition, polymer capsule and fabric softener composition comprising the same LG CHEM, LTD. 2022-01-04 US disclosed
CN-111065673-B Polymerizable composition, polymer capsule comprising the same, and fabric softener composition 株式会社LG化学 2021-10-01 CN disclosed
EP-3325707-B1 COMPOSITIONS FOR MALODOR REDUCTION AND USE THEREOF AGILEX FLAVORS & FRAGRANCES INC (US) 2021-09-29 EP disclosed
US-20200277551-A1 Polymerizable Composition, Polymer Capsule and Fabric Softener Composition Comprising the Same LG CHEM, LTD. (KR) 2020-09-03 US disclosed
CN-111542590-A Water-soluble unit dose articles comprising perfume 宝洁公司 2020-08-14 CN disclosed
EP-1781239-A2 COMPOSITIONS EFFECTIVE IN ALTERING THE PERCEPTION OF MALODOR Patus Ltd (IL) 2007-05-09 EP disclosed
US-20070065394-A1 Compositions effective in altering the perception of malodor PATUS LTD. (IL) 2007-03-22 US disclosed
US-20060165622-A1 Deodorant composition TAKASAGO INTERNATIONAL CORPORATION (JP) 2006-07-27 US disclosed
WO-2006068276-A1 HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR SHOWA DENKO K.K. (JP) 2006-06-29 WO disclosed
US-20050245407-A1 Fragrance composition KAO CORPORATION (JP) 2005-11-03 US disclosed
WO-2005046632-A9 COMPOSITIONS EFFECTIVE IN ALTERING THE PERCEPTION OF MALODOR PATUS LTD (IL) 2005-09-22 WO disclosed
EP-1561476-A1 DEODORANT COMPOSITION Takasago International Corporation (JP) 2005-08-10 EP disclosed
EP-1552814-A1 FRAGRANCE COMPOSITION Kao Corporation (JP) 2005-07-13 EP disclosed
WO-2005046632-A2 COMPOSITIONS EFFECTIVE IN ALTERING THE PERCEPTION OF MALODOR PATUS LTD. (IL) 2005-05-26 WO disclosed
US-5776884-A PERFUME COMPOSITION QUEST INTERNATIONAL B.V. (NL) 1998-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230414474-A1 PROCESS FOR MAKING A COMPOSITION COMPRISING ALKYL POLYGLYCOSIDE AND PERFUME FUT8, PLG, PIGS EPHX1 1640/4885CYP19A1 3299/4885L3MBTL1 4582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.